Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Dec;54 Suppl 2(Suppl 2):S3-7.
doi: 10.1016/j.lungcan.2006.09.014. Epub 2006 Oct 24.

Pharmacogenomics: a reality or still a promise?

Affiliations

Pharmacogenomics: a reality or still a promise?

Gerold Bepler. Lung Cancer. 2006 Dec.

Abstract

Although notable progress has been made in the treatment of non-small-cell lung cancer (NSCLC) in recent years, this disease is still associated with a poor prognosis for most patients. Modern techniques have facilitated the identification of specific genetic factors that may play a role in disease progression and patient response to therapy, prompting research efforts to identify the clinical predictors of outcome for NSCLC. Recent evidence suggests that the application of a pharmacogenomic approach has the potential to greatly improve survival in certain subpopulations of patients with NSCLC, which could profoundly influence the decision-making process used in evolving treatment strategies for this malignancy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of RRM1 levels on gemcitabine in vitro.
Figure 2
Figure 2
Effect of RRM1 levels on carboplatin in vitro.
Figure 3
Figure 3
Study design for the MCC-13208 (MADeIT) trial.

Similar articles

Cited by

References

    1. Rouet P, Smih F, Jasin M. Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Mol Cell Biol. 1994;14:8096–8106. - PMC - PubMed
    1. Liang F, Han M, Romanienko PJ, Jasin M. Homology-directed repair is a major double-strand break repair pathway in mammalian cells. Proc Natl Acad Sci USA. 1998;95:5172–5177. - PMC - PubMed
    1. Bepler G, Gautam A, McIntyre LM, Beck AF, Chervinsky DS, et al. Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer. J Clin Oncol. 2002;20:1353–1360. - PubMed
    1. Pitterle DM, Jolicoeur EC, Bepler G. Hot spots for molecular genetic alterations in lung cancer. In Vivo. 1998;12:643–658. - PubMed
    1. Bepler G, Garcia-Blanco MA. Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer. Proc Natl Acad Sci USA. 1994;91:5513–5517. - PMC - PubMed

Publication types

MeSH terms